Clinical Trial Update: Study of AOC 1044 in Healthy Adult Volunteers and Participants With Duchenne Muscular Dystrophy (DMD) Mutations Amenable to Exon 44 Skipping [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 clinical trial of AOC 1044 in healthy adult volunteers and Duchenne muscular dystrophy patients with exon 44 skipping amenable mutations. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• AOC 1044

Snippet

Sponsor: Avidity Biosciences, Inc. | Conditions: Duchenne Muscular Dystrophy, Exon 44 | Phase 1, Phase 2 | Status: COMPLETED